Prolactinoma

Indication for Bromocriptine

Population group: Suitable for both men and women, only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

To reduce tumour size, particularly in those at risk of optic nerve compression.

For this indication, competent medicine agencies globally authorize below treatments:

2-20 mg in 2-4 divided doses daily

Route of admnistration

Oral

Defined daily dose

2 - 20 mg

Dosage regimen

From 0.5 To 5 mg 4 time(s) per day every day

Detailed description

Paediatric population 7 years and older: 1 mg 2 or 3 times daily, gradually increasing to several tablets daily as required to keep plasma prolactin adequately suppressed. Maximum daily dose recommended in children aged 7 to 12 years is 5 mg. Maximum daily dose recommended in adolescent patients (13-17 years) is 20 mg.

Dosage considerations

Bromocriptine should always be taken with food.

Active ingredient

Bromocriptine is an inhibitor of prolactin secretion and a stimulator of dopamine receptors. The areas of application of bromocriptine are divided into endocrinological and neurological indications.

Read more about Bromocriptine

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner